Fluoroquinolone News and Research

RSS

Fluoroquinolone is a type of drug used to prevent and treat infections. Fluoroquinolones are associated with an increased risk of tendinitis and tendon rupture. This risk is further increased in those over age 60, in kidney, heart, and lung transplant recipients, and with use of concomitant steroid therapy.

Gatifloxacin may be best treatment for drug-resistant typhoid

New research carried out by researchers in Nepal has shown that a new and affordable drug, Gatifloxacin, may be more effective at treating typhoid fever than the drug currently recommended by the World Health Organisation.

27 Jun 2007

WHO ready to tackle drug resistant TB

According to the World Health Organization (WHO) some forms of tuberculosis (TB) are a threat to the security and stability of global health.

25 Jun 2007

New plan to contain extensively drug-resistant TB (XDR-TB)

Hundreds of thousands of cases of drug-resistant tuberculosis (TB) can be prevented and as many as 134 000 lives saved through the implementation of a two-year response plan, published/launched today by the World Health Organization (WHO) and the Stop TB Partnership.

22 Jun 2007

Atypical pathogen treatment vital in hospitalized community-acquired pneumonia patients

Hospitalized patients with community-acquired pneumonia (CAP) who received treatment regimens against atypical disease-causing pathogens reached clinical stability quicker, had fewer days of hospitalization, and had lower mortality rates as a result of their disease, according to a large new study.

16 May 2007

Top 10 diseases by cost

Bladder, prostate and other urinary tract diseases cost Americans nearly $11 billion a year, according to a new report from the National Institutes of Health.

2 May 2007

CDC warns about threat of drug resistant gonorrhoea

According to the U.S. Centre for Disease Control and Prevention (CDC), gonorrhoea affects as many as 700,000 Americans each year and the sexually transmitted disease has now become so drug resistant doctors are running out of options with which to treat it.

16 Apr 2007

MRSA can be a serious post-operative complication

Drug-resistant bacteria can complicate treatment after many surgical procedures.

11 Apr 2007

U.S. tuberculosis rates all-time low in 2006

Drug-resistant TB, including extensively drug-resistant TB, presents significant challenges to treatment and control of the disease in the United States and abroad, according to articles in today's "Morbidity and Mortality Weekly Report" (MMWR).

22 Mar 2007

Measures to combat XDR-TB worldwide

Health experts have confirmed that the emergence of extensively drug-resistant tuberculosis (XDR-TB) poses a serious threat to public health, particularly when associated with HIV.

17 Oct 2006

Antibiotic-resistant MRSA all too common

Researchers in the U.S. say that methicillin-resistant Staphylococcus aureus or MRSA is the most common cause of skin and soft-tissue infections among patients presenting in emergency rooms across the country.

20 Aug 2006

Less antibiotic use in food animals leads to less drug resistance in people

Australia's policy of restricting antibiotic use in food-producing animals may be linked with lower levels of drug-resistant bacteria found in its citizens, according to an article in the May 15 issue of Clinical Infectious Diseases.

18 Apr 2006

FDA bans antibiotic use for poultry

The U.S. Food and Drug Administration (FDA) has banned the use of a poultry antibiotic made by Bayer.

31 Jul 2005

Research explains why Shigella and E. coli are rapidly becoming resistant to fluoroquinolones

Scientists at the Albert Einstein College of Medicine have discovered a novel strategy by which the bacterium that causes tuberculosis may soon be able to resist the effects of antibiotics known as fluoroquinolones.

3 Jun 2005

Antibiotic treatment does not reduce risk of secondary cardiac events

Taking antibiotics weekly for one year does not reduce the risk of a heart attack or other cardiac event for patients with stable coronary artery disease, according to a study funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health. It is published in the April 21, 2005, edition of the New England Journal of Medicine.

20 Apr 2005

Drug-resistant bacteria on uncooked poultry products varies by commercial brand

The presence of drug-resistant, pathogenic bacteria on uncooked poultry products varies by commercial brand and is likely related to antibiotic use in production, according to researchers at the Johns Hopkins Bloomberg School of Public Health.

16 Mar 2005

Three-day antibiotic treatment for treating bladder infections in women

A three-day regimen of the antibiotic amoxicillin-clavulanate is not as effective as ciprofloxacin at treating an uncomplicated bladder infection in women, according to a study conducted by Thomas M. Hooton, M.D., of the University of Washington and Harborview Medical Center, Seattle, and colleagues.

21 Feb 2005

Schering-Plough and Bayer form strategic alliance

Schering-Plough Corporation has announced that it has entered into a strategic agreement with Bayer designed to maximize the companies' pharmaceutical resources while maintaining each company's own strategic interests.

13 Sep 2004

New York health department issues advisory on gonorrhea

In response to a recent increase in drug resistant gonorrhea, the New York Department of Health and Mental Hygiene (DOHMH) is issuing a health alert to New York City medical providers announcing alternative treatment recommendations for individuals infected with gonorrhea.

5 May 2004

Drug-resistant gonorrhea is a major public health concern

The increasing resistance to fluoroquinolones effectively eliminates an entire class of antibiotics and leaves only one class of drugs -- cephalosporins -- as the first-line therapy in the treatment of gonorrhea. There are currently no other major groups of antibiotics left to treat gonorrhea.

2 May 2004